Alembic Pharma gets USFDA nod for bipolar depression drug

The approved product is therapeutically equivalent to the reference listed drug product (RLD) Latuda tablets of Sunovion Pharmaceuticals Inc.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news